What Is the Optimal Monotherapy in Korean Drug-Naïve Type 2 Diabetic Patients?: The Practical Evidence of Antidiabetic Monotherapy Study
Main Authors: | Ji Hun Choi, Won-Young Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Diabetes Association
2011-02-01
|
Series: | Diabetes & Metabolism Journal |
Online Access: | http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-35-23.pdf |
Similar Items
-
Comparison of the Efficacy of Glimepiride, Metformin, and Rosiglitazone Monotherapy in Korean Drug-Naïve Type 2 Diabetic Patients: The Practical Evidence of Antidiabetic Monotherapy Study
by: Kun Ho Yoon, et al.
Published: (2011-02-01) -
Comparison of antidiabetic drugs added to sulfonylurea monotherapy in patients with type 2 diabetes mellitus: A network meta-analysis.
by: Dan Qian, et al.
Published: (2018-01-01) -
Characterization of metabolic parameters in responders and nonresponders treated with canagliflozin monotherapy in drug-naive subjects with Type 2 diabetes
by: Eiji Kutoh, et al.
Published: (2018-01-01) -
Durability of pneumatic dilation monotherapy in treatment-naive achalasia patients
by: Abid T. Javed, et al.
Published: (2019-11-01) -
Intravitreal bevacizumab monotherapy for treatment-naïve polypoidal choroidal vasculopathy
by: Jay Kumar Chhablani, et al.
Published: (2013-01-01)